Who is sponsoring NCT02106949?

NCT02106949 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT02106949?

Interventions in NCT02106949: SMS contact with patient after discharge in intervention group.

What condition does NCT02106949 study?

NCT02106949 studies Patients Having Realized a Suicide Attempt.

Is NCT02106949 still recruiting?

NCT02106949 is currently completed. Last updated 23 January 2025.

Last reviewed 2025-01-23 · How we verify

NCT02106949

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short Message System (SMS) Monitoring Intended for the Suicidal Patients

Completed Phase 3 Last updated 23 January 2025

What this trial tests

Phase 3 trial testing SMS contact with patient after discharge in intervention group in Patients Having Realized a Suicide Attempt in 530 participants. Completed in 22 March 2019.

Timeline

20 August 2014

Primary endpoint
22 March 2019

22 March 2019

Quick facts

Lead sponsor	University Hospital, Brest
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	530
Start date	20 August 2014
Primary completion	22 March 2019
Estimated completion	22 March 2019
Sites	13 locations across France

Drugs / interventions tested

SMS contact with patient after discharge in intervention group

Conditions studied

Patients Having Realized a Suicide Attempt — all drugs for Patients Having Realized a Suicide Attempt →

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Patients Having Realized a Suicide Attempt. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study wants to prove that SMS monitoring reduced the number of suicide attempts in six months according to the beginning of its implementation in the group of the patients benefiting SMS compared with the group of patients benefiting from the usual care.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Psychosocial interventions for self-harm in adults.
Hawton K, Witt KG, Taylor Salisbury TL, Arensman E, et al · · 2016 · cited 109× · PMID 27168519 · DOI 10.1002/14651858.cd012189
SIAM (Suicide intervention assisted by messages): the development of a post-acute crisis text messaging outreach for suicide prevention.
Berrouiguet S, Alavi Z, Vaiva G, Courtet P, et al · · 2014 · cited 39× · PMID 25404215 · DOI 10.1186/s12888-014-0294-8
Toward mHealth Brief Contact Interventions in Suicide Prevention: Case Series From the Suicide Intervention Assisted by Messages (SIAM) Randomized Controlled Trial.
Berrouiguet S, Larsen ME, Mesmeur C, Gravey M, et al · · 2018 · cited 23× · PMID 29321126 · DOI 10.2196/mhealth.7780

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02106949 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 23 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02106949.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing